Tags: Drug.

Ensituximab is a chimeric monoclonal antibody used in the treatment of cancers.Ensituximab was developed by Neogenix Oncology Inc.

ATC prefix
none
CAS number
1092658-06-4
FDA UNII code
F988K568V2

Loading...

This page contains content from the copyrighted Wikipedia article "Ensituximab"; that content is used under the GNU Free Documentation License (GFDL). You may redistribute it, verbatim or modified, providing that you comply with the terms of the GFDL.